味道和气味的变化会影响化学疗法的儿童的营养状况
Audrey Grain1,2, Margaux Camuset1, Christèle Gras-Leguen3
1Paediatric Haematology and Oncology Department, CHU of Nantes, Nantes, France.
Acta paediatrica (Oslo, Norway : 1992)
|June 28, 2023
概括
味觉和嗅觉的改变 (TSA) 在化疗期间影响超过70%的儿科癌症患者,影响食欲,并可能导致体重减轻. 早期发现TSA对于管理这些年轻患者的营养状况至关重要.
科学领域:
- 儿科瘤学 儿科瘤学
- 临床营养学 临床营养学
- 化疗的副作用 化疗的副作用
背景情况:
- 味觉和嗅觉改变 (TSA) 是儿童癌症患者常见的化疗副作用.
- 对于TSA对这种脆弱人群的营养状况的影响需要进一步调查.
- 需要一个验证的工具来检测TSA在接受化疗的儿童.
研究的目的:
- 为了确定在接受化疗的儿科癌症患者中TSA的发生率.
- 评估TSA对营养状况和饮食行为的影响.
- 开发和验证一个复合得分 (Gustonco) 来检测儿童的TSA.
主要方法:
- 研究了一组接受化疗的儿科瘤患者队列.
- 用Gustonco问卷评估了味道和气味的变化.
- 饮食行为和营养状况 (包括重大体重减轻) 被评估在化疗开始后的1,3,6个月.
主要成果:
- 71.7%的患者在1个月后报告TSA,在3个月和6个月后持续存在.
- 从1个月开始观察到食欲变化.
- 6个月高的Gustonco得分与严重的体重减轻有关.
结论:
- 化疗经常导致儿童癌症患者的味道和气味变化.
- 这些感官变化与营养状况受损有关,特别明显在化疗后6个月.
- 古斯顿科得分显示了检测TSA及其与营养结果的关联的潜力.
相关概念视频
Taste Buds and Receptors
2.3K
Gustation, or the sense of taste, is intrinsically linked to the anatomical structures located on the tongue. This organ's surface, along with the entirety of the oral cavity, is adorned with stratified squamous epithelium. Evident on the tongue are elevated structures known as papillae (singular = papilla), which house the mechanisms for the transduction of gustatory stimuli. Four distinct types of papillae exist, each identified by their unique morphological attributes: the circumvallate,...
2.3K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
208
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
208
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
353
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
353
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
251
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
251
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
326
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
326
Cancer Therapies
7.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.8K


